Clinical trial
Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects
NCT00258141 · J. Uriach and Company, Industry · Unknown status
Key facts
| NCT number | NCT00258141 |
|---|---|
| Title | Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects |
| Official title | A Placebo-Controlled, Double-Blind, Cross-Over Study With Rupatadine 10 Mg in 30 Mosquito-Bite Allergic Adult Subjects |
| Lead sponsor | J. Uriach and Company, Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Allergy |
| Intervention type | Drug |
| Interventions | Rupatadine, Placebo |
| Enrollment | 30 |
| First posted | Nov 24, 2005 |
| Last update posted | Nov 24, 2005 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: